KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to -$169.9 million.

  • Emergent BioSolutions' Other Working Capital Changes fell 84.67% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.7 million, marking a year-over-year increase of 71.24%. This contributed to the annual value of -$169.9 million for FY2024, which is 1352.14% down from last year.
  • Emergent BioSolutions' Other Working Capital Changes amounted to -$169.9 million in FY2024, which was down 1,352.14% from -$11.7 million recorded in FY2023.
  • Emergent BioSolutions' Other Working Capital Changes' 5-year high stood at $26.9 million during FY2020, with a 5-year trough of -$169.9 million in FY2024.
  • Its 3-year average for Other Working Capital Changes is -$53.9 million, with a median of -$11.7 million in 2023.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 162.58% in 2022, then tumbled by 1,352.14% in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Other Working Capital Changes stood at $26.9 million in 2020, then slumped by 218.22% to -$31.8 million in 2021, then surged by 162.58% to $19.9 million in 2022, then tumbled by 158.79% to -$11.7 million in 2023, then tumbled by 1,352.14% to -$169.9 million in 2024.